however, its therapeutic effects eventually wear off and can even cause motor complications, such as fluctuations and dyskinesias
Serving Mumbai, Bandra, Khar, Andheri, South Mumbai , and India .
Why are GLP-1 medications not one-size-fits-all
The selection process followed the recommendations of the PRISMA-ScR checklist [2], and a PRISMA flowchart of study selection is presented following the PRISMA statement [9]
Large observational studies from electronic health records show that people prescribed GLP-1 agonists for diabetes or obesity are associated with fewer alcohol-related hospitalizations compared to those on other medications
The early clinical data is suggestive, and the research community continues to investigate their potential applications